Trial Profile
A real world study evaluating efficacy and safety of Teriparatide and Denosumab combination in patients with severe lumbar spine and hip osteoporosis in a specialist bone health clinic in Ireland
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 08 Jul 2017 New trial record